Cargando…

The metabolomics of psoriatic disease

Metabolomics is an emerging new “omics” field involving the systematic analysis of the metabolites in a biologic system. These metabolites provide a molecular snapshot of cellular activity and are thus important for understanding the functional changes in metabolic pathways that drive disease. Recen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Di, Afifi, Ladan, Jeon, Caleb, Trivedi, Megha, Chang, Hsin Wen, Lee, Kristina, Liao, Wilson
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562362/ https://www.ncbi.nlm.nih.gov/pubmed/28824870 http://dx.doi.org/10.2147/PTT.S118348

Ejemplares similares

2296: Functional analysis of the cutaneous microbiome in psoriatic disease
por: Yan, Di, et al.
Publicado: (2018)

Guselkumab for the Treatment of Psoriasis: A Review of Phase III Trials
por: Nakamura, Mio, et al.
Publicado: (2017)

Metabolomics Studies in Psoriatic Disease: A Review
por: Koussiouris, John, et al.
Publicado: (2021)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
por: Sekhon, Sahil, et al.
Publicado: (2017)

Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis
por: Armstrong, April W., et al.
Publicado: (2014)

Psoriatic Disease and Tuberculosis Nowadays
por: Balato, Nicola, et al.
Publicado: (2012)

RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways
por: Ahn, Richard, et al.
Publicado: (2018)

Clinical and Genetic Risk Factors Associated with Psoriatic Arthritis among Patients with Psoriasis
por: Yan, Di, et al.
Publicado: (2018)

Cardiovascular Comorbidities in Psoriatic Disease
por: Szentpetery, Agnes, et al.
Publicado: (2019)

JAK Inhibitors in Psoriatic Disease
por: Megna, Matteo, et al.
Publicado: (2023)

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
por: Ly, Karen, et al.
Publicado: (2019)

Deucravacitinib for the Treatment of Psoriatic Disease
por: Lé, Ana Maria, et al.
Publicado: (2022)

Identifying Serum Metabolomic Markers Associated with Skin Disease Activity in Patients with Psoriatic Arthritis
por: Choksi, Hani, et al.
Publicado: (2023)

Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization
por: Chang, Hsin-Wen, et al.
Publicado: (2018)

Multicentric Squamous Cell Carcinoma Arising on Psoriatic Plaque
por: Gupta, Megha, et al.
Publicado: (2013)

Psoriatic arthritis
por: Ocampo D, Vanessa, et al.
Publicado: (2019)

Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis
por: Mease, Philip J., et al.
Publicado: (2014)

Comparative effectiveness of biologics and targeted therapies for psoriatic arthritis
por: Zhang, Hanzhe, et al.
Publicado: (2021)

Dietary Behaviors in Psoriasis: Patient-Reported Outcomes from a U.S. National Survey
por: Afifi, Ladan, et al.
Publicado: (2017)

Measuring Disease Activity in Psoriatic Arthritis
por: Wong, Priscilla C. H., et al.
Publicado: (2012)

Frequency and Management of Sleep Disturbance in Adults with Atopic Dermatitis: A Systematic Review
por: Jeon, Caleb, et al.
Publicado: (2017)

From the Skin to Distant Sites: T Cells in Psoriatic Disease
por: Reali, Eva, et al.
Publicado: (2023)

Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis
por: Peluso, Rosario, et al.
Publicado: (2019)

Dual biologic therapy for recalcitrant psoriasis and psoriatic arthritis
por: Thibodeaux, Quinn, et al.
Publicado: (2019)

Psoriatic Arthritis: An Update
por: Lloyd, Peter, et al.
Publicado: (2012)

Genetic epidemiology: Psoriatic arthritis
por: Barton, Anne C
Publicado: (2002)

Treatment guidelines in psoriatic arthritis
por: Ogdie, Alexis, et al.
Publicado: (2020)

Immunological Memory of Psoriatic Lesions
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020)

Upadacitinib for the treatment of psoriatic arthritis
por: Fonseca, Diogo, et al.
Publicado: (2023)

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
por: Barbarroja, Nuria, et al.
Publicado: (2019)

Altered Fecal Metabolomics and Potential Biomarkers of Psoriatic Arthritis Differing From Rheumatoid Arthritis
por: Wang, Nan, et al.
Publicado: (2022)

Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis
por: Bergman, Martin, et al.
Publicado: (2017)

Assessing Disease Activity in Psoriatic Arthritis: A Literature Review
por: Tucker, Laura J., et al.
Publicado: (2018)

Inhibition of Phosphodiesterase-4 in Psoriatic Arthritis and Inflammatory Bowel Diseases
por: Picchianti-Diamanti, Andrea, et al.
Publicado: (2021)

Axial Psoriatic Disease: Clinical and Imaging Assessment of an Underdiagnosed Condition
por: Giovannini, Ivan, et al.
Publicado: (2021)

Enthesitis and Dactylitis in Psoriatic Disease: A Guide for Dermatologists
por: Bagel, Jerry, et al.
Publicado: (2018)

Metabolomics analysis reveals cytotoxic effects of ouabain towards psoriatic keratinocytes via impairment of glutathione metabolism
por: Zhou, Xuan, et al.
Publicado: (2023)

Metabolomics Biomarkers for Detection of Colorectal Neoplasms: A Systematic Review
por: Erben, Vanessa, et al.
Publicado: (2018)

Editorial: Immunology of Psoriatic Disease
por: Reali, Eva, et al.
Publicado: (2019)

The cardiometabolic conditions of psoriatic disease
por: Toussirot, Eric, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7t29dgk37dtbk350fcf716770b